Osteoporosis International

, Volume 14, Issue 10, pp 835–842

Soy protein consumption and bone mass in early postmenopausal Chinese women

  • Suzanne C. Ho
  • Jean Woo
  • Silvia Lam
  • Yuming Chen
  • Aprille Sham
  • Joseph Lau
Original Article

Abstract

Recent interest has been shown in the potential beneficial effects of phytoestrogens on bone health. As the early years of menopause are a period of rapid bone loss, and the risk for osteoporosis increases substantially, the habitual intake of soy protein and isoflavones may play a role in the retardation of bone loss. This paper reports the results of the baseline cross-sectional analysis of the association between dietary soy protein intake and bone mineral density/content in a population-based study of Chinese women. The sample comprised 454 healthy Chinese women (mean age 55.1±3.57) within the first 12 years of postmenopause. We estimated the dietary intake of soy protein and isoflavones, and other key nutrients, including dietary protein and calcium, using the quantitative food frequency method. Bone mineral density (BMD) and content (BMC) at the spine, hip and total body were measured with a dual energy X-ray densitometer (Hologic 4500A). Soy protein consumption was categorized as quartiles of intake, and related to BMD values at the spine and hip, and BMC of total body. Stratified analyses were carried out among women within or at least 4 years postmenopausal. We observed few differences in BMD/BMC values among the intake quartiles in women within the first 4 years of menopause. However, among the later postmenopausal women, we noted a dose-response relationship with increasing higher BMD values at the trochanter, intertrochanter as well as the total hip and total body with increasing soy protein intake quartiles (P<0.05 from tests for trend). The BMD values differed by about 4–8% between the first and fourth soy protein intake quartiles. Though women from the fourth intake quartile had a 2.9% higher BMD value compared with those from the first intake quartile, the difference was not statistically significant. Stepwise multiple linear regression analyses showed the association between soy intake quartiles and hip BMD as well as total body BMC values remained after adjusting for body weight, which was retained in the final model. Analyses based on soy isoflavones content yielded similar results. This study demonstrated that, among women after the initial few years postmenopausal, soy protein/isoflavones intake had a modest but significant association with hip BMD as well as total body BMC. The effects of soy protein and soy isoflavones on bone health should be further explored in populations with habitual dietary soy intake.

Keywords

Bone mineral content Bone mineral density Chinese postmenopausal women Soy protein 

References

  1. 1.
    Schwartz AV, Kelsey JL, Maggi S, Tuttleman M, Ho S C, Jonsson PV, Poor G, Sisson de Castro JA, Xu, L, Matkin CC, Nelson LM, Heyse SP (1999) International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for research on aging. Osteoporos Int 9:242–253CrossRefPubMedGoogle Scholar
  2. 2.
    Anderson JJB, Ambrose WW, Garner SC, Ohue T (1997) The effects of phytoestrogens on bone. Nutr Res 17:1617–1631CrossRefGoogle Scholar
  3. 3.
    Arjmandi BH, Alekel L, Hollis BW, Amin D, Stacewicz-Sapuntzakis M, Guo P, Kukreja SC (1996) Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 126:161–167PubMedGoogle Scholar
  4. 4.
    Potter SM, Baum JA, Teng H, Stillman RJ, Erdman JW Jr (1998) Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 68:1375S–1379SPubMedGoogle Scholar
  5. 5.
    Alekel DL, Germain AS, Peterson CT, Hanson KB, Stewart JW, Toda T (2000) Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am J Clin Nutr 72:844–852PubMedGoogle Scholar
  6. 6.
    Gallagher JC, Rafferty K, Haynatzka V, Wilson M (1999) Effect of soy protein on bone metabolism. Presented at Third international symposium on the role of soy in preventing and teaching chronic disease, Oct 31–Nov 3, Washington D.C.Google Scholar
  7. 7.
    Ho SC, Chan SG, Yi Q, Wong E, Leung PC (2001) Soy intake and the maintenance of peak bone mass in Hong Kong Chinese Women. J Bone Miner Res 16:1363–1369PubMedGoogle Scholar
  8. 8.
    Tsuchida K, Mizushima S, Toba M, Soda K (1999) Dietary soybeans intake and bone mineral density among 995 middle-aged women in Yokohama. J Epidemiol 9:14–19PubMedGoogle Scholar
  9. 9.
    Mei JJM, Yeung SSC, Kung AWC (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86:5217–5221PubMedGoogle Scholar
  10. 10.
    Somekawa Y, Chiquchi M, Ishibashi T, Aso T (2001) Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 97:109–115CrossRefPubMedGoogle Scholar
  11. 11.
    Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H (2000) Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int 11:721–724CrossRefPubMedGoogle Scholar
  12. 12.
    US Department of Health, Education and Welfare & Food & Agriculture Organization of the United Nations (1972) Food composition table for use in East AsiaGoogle Scholar
  13. 13.
    Franke AA, Custer LJ, Cerna CM, Narala KK (1994) Quantitation of phytoestrogens in legumes by HPLC. J Agric Food Chem 42:1905–1913Google Scholar
  14. 14.
    Reinli K, Block G (1996) Phytoestrogen content of foods—a compendium of literature values. Nutr Cancer 26:123–148PubMedGoogle Scholar
  15. 15.
    Wang HJ, Murphy PA (1994) Isoflavone content in commercial soybean foods. J Agric Food Chem 42:1666–1673Google Scholar
  16. 16.
    Anderson JJW (1997) Isoflavone concentration in soyfoods. Presented at the American Dietetic Association 80th Annual Meeting and Exhibition, October 27–30, Boston, MassachusettsGoogle Scholar
  17. 17.
    Recker R, Lappe J, Davies K, Heaney R (2000) Characterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 15:1965–1973PubMedGoogle Scholar
  18. 18.
    Ho SC, Hsu S, Leung PC, Chan C, Swaminathan R (1993) Anthropometric measurements and bone mineral density among young Chinese adult women aged 21–40. Ann Epidemiol 3:256–263PubMedGoogle Scholar
  19. 19.
    Ho SC, Leung PC, Swaminathan R, Chan C, Chan SG, Lindsay R (1994) Determinants of bone mass in Chinese women aged 21–40. II Pattern of dietary calcium intake and association with bone mineral density. Osteoporos Int 4:167–175PubMedGoogle Scholar
  20. 20.
    Ho SC, Eric Wong, Chan SG, Lau J, Chan C, Leung PC (1997) Determinants of peak bone mass in Chinese women aged 21–40 years. III. Physical activity and bone mineral density. J Bone Miner Res 12:1262–1271PubMedGoogle Scholar
  21. 21.
    Ishida H, Uesugi T, Hirai K, Toda T, Nukaya H, Yokotsuka K, Tsugi K (1998) Preventive effects of the plant isoflavones, daidzin and genistin, on bone loss in ovariectomized rats fed a calcium-deficient diet. Biol Pharm Bull 21:62–66PubMedGoogle Scholar
  22. 22.
    Anderson JJ, Ambrose WW, Garner SC (1998) Biophasic effects of genistein on bone tissue in the ovarietomized, lactating rat model. Proc Soc Exp Med 217:345–350Google Scholar
  23. 23.
    Blair H, Jordan SE, Peterson TG, Barnes S (1996) Variable effect of tyrosine kinase inhibitors on avian osteoclastic activity and reduction of bone loss in ovariectomized rats. J Cell Biochem 61:629–637CrossRefPubMedGoogle Scholar
  24. 24.
    Arjmandi BH, Birnbaum R, Goyal NV, Getlinger MJ, Juma S, Alekel L, Hasler CM, Drum ML, Hollis BW, Kukreja SC (1998) Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am J Clin Nutr 68:1364S–1368SPubMedGoogle Scholar
  25. 25.
    Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kukreja SC (1998) Role of soy protein with normal or reduced isoflavones content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 68:1358S–1363SPubMedGoogle Scholar
  26. 26.
    Anderson JJ, Chen X, Boass A, Symons M, Kohlmeier M, Renner JB, Garner SC (2002) Soy isoflavones: no effects on bone mineral content and bone mineral density in healthy, menstruating young adult women after one year. J Am Coll Nutr 21:388–393PubMedGoogle Scholar
  27. 27.
    Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Antonia Pizzoleo M, Cincotta M, Altavilla D, Ientile R, Squadrito F (2002) Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Miner Res 17:1904–1912PubMedGoogle Scholar
  28. 28.
    Anderson JJB, Anthony, Messina M, Garner SC (1999) Effects of phyto-oestrogens on tissues. Nutr Res Rev 12:75–116Google Scholar
  29. 29.
    Fanti P, Monier-Faugere MC, Geng Z, Schmidt J, Morris PE, Cohen D, Malluche HH (1998) The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats. Osteoporos Int 8:274–281PubMedGoogle Scholar
  30. 30.
    Anderson JJB, Miller CP (1998) Lower lifetime estrogen exposure among vegetarians as a possible risk factor for osteoporosis: a hypothesis. Veg Nutr 2:4–12Google Scholar
  31. 31.
    Arjmandi BH, Khalil DA, Smith BJ, Lucas EA, Juma S, Payton ME, Wild RA (2003) Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J Clin Endocrinol Metab 88:1048–1054CrossRefPubMedGoogle Scholar
  32. 32.
    LandinWihelmsen K, Nilsson A, Bosaeus I, Bengtsson B-A (2003) Growth hormone increases bone mineral content in postmenopausal osteoporosis: a randomized, placebo-contolled trial. J Bone Miner Res 18:393–405PubMedGoogle Scholar
  33. 33.
    Ho SC, Donnan S P B, Sham A (1988) Dietary intake among Chinese elderly in Hong Kong. J Hum Nutr Dietet 1:205–215Google Scholar
  34. 34.
    Ho SC, Woo J, Leung SSF, Sham A, Lam TH, Janus ED (2000) Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J Nutr 130:2590–2593PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2003

Authors and Affiliations

  • Suzanne C. Ho
    • 1
  • Jean Woo
    • 2
  • Silvia Lam
    • 1
  • Yuming Chen
    • 1
  • Aprille Sham
    • 1
  • Joseph Lau
    • 3
  1. 1.Department of Community and Family Medicine, School of Public Health, Prince of Wales HospitalThe Chinese University of Hong Kong, 4th FloorHong Kong
  2. 2.Department of Medicine and TherapeuticsThe Chinese University of Hong KongHong Kong
  3. 3.Centre of Epidemiology and BiostatisticsThe Chinese University of Hong KongHong Kong

Personalised recommendations